| Cytovene (ganciclovir) / Roche |
NCT03004261: CMV-CTL for the Treatment of CMV Infection After HSCT |
|
|
| Completed | 4 | 5 | RoW | donor derived cytomegalovirus specific T lymphocytes, cytomegalovirus specific T lymphocytes, Foscarnet, Ganciclovir | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China | Cytomegalovirus Infections, Hematological Disease | 12/21 | 12/21 | | |
2018-003300-39: Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients. Ensayo clínico de eficacia y seguridad de la combinación de profilaxis de duración reducida seguida de profilaxis inmunoguiada en pacientes transplantados de pulmón. |
|
|
| Not yet recruiting | 3 | 150 | Europe | Tablet, Powder for concentrate for solution for infusion, VALCYTE, CYMEVENE | Fundación para la Investigación Biomédica de Córdoba, Instituto de Salud Carlos III | Cytomegalovirus Infection in subjects who underwent lung transplantation. Infección por citomegalovirus en pacientes trasplantados de pulmón., Virus Infection in subjects who underwent lung transplantation. Infección por virus en pacientes trasplantados de pulmón., Diseases [C] - Virus Diseases [C02] | | | | |
NCT06439342: A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections |
|
|
| Not yet recruiting | 3 | 20 | RoW | Maribavir, TAK-620 | Takeda | Cytomegalovirus (CMV) | 02/27 | 02/27 | | |
2020-005197-10: Nanatinostat and Valganciclovir in R/R EBV+ Lymphoma (“NAVAL-1”) |
|
|
| Not yet recruiting | 2 | 150 | Europe | Nanatinostat, Valganciclovir, ganciclovir, VRx-3996, Film-coated tablet, Powder for concentrate for solution for infusion, Valganciclovir hydrochloride | Viracta Therapeutics, Inc., Viracta Therapeutics, Inc. | Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas, Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas, Diseases [C] - Cancer [C04] | | | | |
NCT06474442: A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis |
|
|
| Not yet recruiting | 2 | 40 | RoW | BD111 Injection (investigational new drug), BD111 Lentivirus-like particles, also called HSV-1-erasing lentiviral particles (HELP), Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Eye gel+Valacilovir Tablets+Prednisolone Acetate Eye Drops | Shanghai BDgene Co., Ltd. | Herpes Simplex Virus Type I Stromal Keratitis | 12/25 | 12/26 | | |
NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid |
|
|
| Recruiting | 1 | 12 | RoW | Intratumoral administration of Stimotimagene copolymerplasmid, Intravenous administration of Ganciclovir (Cymeven®) | Gene Surgery LLC | Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms | 12/23 | 12/23 | | |
